CD8A and neoplasm: In tumor-bearing mice, GSK3β inhibition did not ameliorate tumor-infiltrating CD8+ T cells and antitumor treatment efficacy (Extended Data Fig. 10g–i), suggesting that LC has a GSK-independent antitumor function.